Latest Hypolipidemic agent Stories
According to court documents, on June 1st, 2012, Danielle Woolens filed a lawsuit in the Louisiana Eastern District Court (case no.
A new report published in The Lancet states that more people should be given cholesterol-lowering drugs and statins to help decrease the number of strokes and heart attacks.
Mark Rosenberg, M.D.
A novel monoclonal antibody identified in a new study dramatically lowered circulating LDL cholesterol by 40 percent to 72 percent, a development with potential to provide a new option for patients who are resistant to cholesterol-lowering drugs such as statins or to the current standard of care.
Low LDL cholesterol in patients with no history of taking cholesterol-lowering drugs predates cancer risk by decades, suggesting there may be some underlying mechanism affecting both cancer and low LDL cholesterol that requires further examination.
Regular use of cholesterol-lowering statin drugs may be associated with a modest reduction in risk for developing Parkinson disease, particularly among younger patients.
- Growing in low tufty patches.